The Finalists 2017

Categories and Finalists 2017

OBN is delighted to announce the finalists of its 9th OBN Awards which celebrate innovation and achievement across the UK life sciences industry.

Best Start-up Biotech

Kindly sponsored by

EY logo horizontal tagline and yellow

Finalists 2017

Microbiotica
for transforming personalised medicine with microbiome science
Vaccitech
for creating novel vaccines that elicit strong responses from helper
and cytotoxic T-cells
Tusk Therapeutics
for developing novel immune modulating cancer therapeutics
that target the tumour microenvironment
Orbit Discovery
for utilising novel strategies to develop peptide-based therapeutics
for chronic diseases

Best Emerging Biotech

Kindly sponsored by

Covance Logo 155x70

Finalists 2017

Rexgenero
for realising the potential of stem cells to create cell therapies for
vascular, neurological and other diseases
Macrophage Pharma
for developing small molecule drugs to selectively activate tumour associated macrophage in order to enhance tumour killing
Exscientia
for applying AI and big data processing to accelerate drug discovery and development

Best Established Biotech

Kindly sponsored by

Penningtons_Manches_Logo

Finalists 2017

Bicycle Therapeutics
for creating first in class bicyclic peptides drugs with
enhanced anti-tumour properties
Immunocore
for leading the way in developing TCR-based drugs for new cancer, autoimmune and infectious disease treatments
PsiOxus Therapeutics
for realising the potential of immuno-oncolytic viruses for treatment of solid tumours
F-star biotechnology
for developing novel bispecific antibodies for immunoncology

Best Start-up Medtech

Kindly sponsored by

Premier Research logo 230x125

Finalists 2017

Oxford Endovascular
for creating novel ‘origami-like’ stents with improved performance and lower patient risk for treatment of intracranial aneurysms
Oxford Enhanced Medical
for developing a uniquely disruptive hybrid ultrasound and
radar medical imaging technology that provides MRI quality images
in a portable, affordable, and safe format
Jupiter Diagnostics
for developing a fast, simple and low-cost handheld reader
for point-of-care blood testing

Best Emerging Medtech

Kindly sponsored by

Team Consulting Resized

Finalists 2017

Medherant
for creating next-generation transdermal drug delivery patches
using novel polymer and adhesive technologies
Blue Earth Diagnostics
for commercialising novel PET imaging agents
in the cancer diagnostics arena
OxSonics Limited
for realising ultrasound-based technology to enhance the
anti-tumour effects of proven anti-cancer drugs
Cambridge Respiratory Innovations
for developing enhanced diagnostic capabilities for respiratory disease
based on the profile of carbon dioxide release during expiration
Perspectum Diagnostics
for commercialising LiverMultiScan, a non-invasive medical imaging
software tool which enhances the effectiveness of the diagnostic pathway
for patients with chronic liver disease

Best Contract Research Organisation

Finalists 2017

Imanova Limited
for specialising in applying PET and MRI scanning techniques
to improve productivity in early drug development and
to help improve disease understanding
Sygnature Discovery
for providing integrated drug discovery services from state-of-the-art facilities and colocalised industry-experienced and recently qualified scientists
XenoGesis
for specialising in preclinical drug metabolism and pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation to
assist early identification of ‘winners’

Best Emerging UK Synthetic Biotech

Kindly sponsored by

SynbiCITE

Finalists 2017
judged by SynbiCITE

Synpromics Ltd
for being the leading developer of synthetic promoters and
provider of gene expression solutions to the Biotech industry
Chain Biotech
for it’s new class of biotherapeutic being transformative and
offering more effective and affordable treatment for chronic disease
Oxford Genetics
for its expertise in designing DNA and using this to optimise the expression
of proteins, improving viral delivery systems and cell line engineering

Best Implementation of Digital Healthcare

Kindly sponsored by

Jamescowperkreston New 230x125

Finalists 2017

Isansys Lifecare
for transforming care of patients on critical care pathways,
in hospital or at home, using compliant wireless patient
monitoring devices and data handling systems
Adherium
for providing smart personal medication monitoring systems
to help patients manage their chronic respiratory conditions
Aparito
for enabling remote patient monitoring in the rare disease arena
using wearable devices and disease-specific mobile apps
OxeHealth
for providing validated technology for digital camera-based medical grade vital sign, human activity and behaviour monitoring in the healthcare and other diverse settings

Best UK Life Sciences Incubator

Kindly sponsored by

Precision for Oncology - sponsor logo

Finalists 2017

BioHub at Alderley Park
for the epicentre for life science technology in the North West

 

Stevenage Bioscience Catalyst
for providing a home for growing life sciences companies
within a short distance of London

 

Babraham Bioscience Technologies
for playing a key role in the nurturing Cambridge’s burgeoning
early stage biosciences ecosystem

Highest Impact Investor

Kindly sponsored by

Milton Park Logo 220x115

Finalists 2017

Finalists companies for the Highest Impact Investor Category will be announced and judged by the ITSIG board.